NCT06340620

Brief Summary

This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started Mar 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Mar 2024Dec 2027

First Submitted

Initial submission to the registry

March 15, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

March 25, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 1, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

April 1, 2024

Status Verified

March 1, 2024

Enrollment Period

2.7 years

First QC Date

March 15, 2024

Last Update Submit

March 25, 2024

Conditions

Keywords

Endoscopic ultrasoundEndoSound Vision SystemRandomized trial

Outcome Measures

Primary Outcomes (1)

  • Rate of successful completion of the requisite EUS examination

    Rate of successful completion of the requisite examination during EUS between the EndoSound Vision System and standard echoendoscopes will be assessed, compared as a percentage of successfully completed examinations between the standard echoendoscope and Endosound Vision System.

    1 day

Secondary Outcomes (9)

  • Ease of maneuverability of the device

    1 day

  • Quality of EUS imaging

    1 day

  • Ease of performing tissue acquisition

    1 day

  • Diagnostic adequacy of procured specimen on onsite evaluation

    7 days

  • Diagnostic adequacy of procured specimen in cell block

    7 days

  • +4 more secondary outcomes

Study Arms (2)

Standard echoendoscope

ACTIVE COMPARATOR

Standard echoendoscope will be used and EUS examination will be performed per standard of care.

Device: Endoscopic ultrasound examination

EndoSound Vision System

ACTIVE COMPARATOR

EndoSound Vision System will be used and EUS examination will be performed per standard of care.

Device: Endoscopic ultrasound examination

Interventions

Endoscopic ultrasound examination will be performed.

EndoSound Vision SystemStandard echoendoscope

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Any patient undergoing EUS examination for evaluation of the pancreas, bile duct, mediastinal or intraabdominal lymph nodes, or luminal lesions in the esophagus, stomach, duodenum or colon.

You may not qualify if:

  • Age \< 18 years.
  • Unable to obtain consent for the procedure from either the patient or LAR.
  • Intrauterine pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Orlando Health

Orlando, Florida, 32806, United States

RECRUITING

MeSH Terms

Conditions

Pancreatic DiseasesPancreatic NeoplasmsPancreatic CystDigestive System NeoplasmsBile Duct DiseasesBile Duct NeoplasmsGastrointestinal Neoplasms

Condition Hierarchy (Ancestors)

Digestive System DiseasesNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsEndocrine System DiseasesCystsBiliary Tract DiseasesBiliary Tract NeoplasmsGastrointestinal Diseases

Study Officials

  • Ji Young Bang, MD MPH

    Orlando Health, Digestive Health Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 15, 2024

First Posted

April 1, 2024

Study Start

March 25, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

April 1, 2024

Record last verified: 2024-03

Locations